Trial intelligence / Profile preview

CYTOCINON: Oxytocin plus misoprostol to prevent postpartum hemorrhage

2009-013177-18Phase 3Terminated

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jul 2009
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in postpartum hemorrhage (PPH) comparing Oxytocin alone with Oxytocin plus misoprostol (2 arms). Started Jul 2009; status: terminated.

02

Drugs

oxytocinmisoprostol
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on 2009-013177-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-013177-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call